High-Concentration Hydrogen Inhalers Pose Explosion Risk, Study Warns
- Authors
- Yusuke Ichikawa, Bunpei Sato, Yoshiyasu Takefuji, Fumitake Satoh
- Journal
- International Journal of Risk & Safety In Medicine
- Year
- 2026
- DOI
- 10.1177/09246479251414573
- Study Type
- clinical
- Peer Reviewed
- Yes
- Country
- Japan
- Health Condition
- Oxidative Stress
- Body System
- Respiratory
TL;DR
Some hospitals in Japan have been using super-strong hydrogen inhalers to treat patients, but they're so concentrated they can literally explode—both the machines themselves and even inside people's lungs. Researchers found that using weaker hydrogen inhalers (less concentrated) works just as well for helping your body but won't explode, so doctors should switch to the safer version right away.
Key Finding
High-concentration hydrogen inhalers (above 10% hydrogen) have caused multiple device explosions and at least one documented explosion inside a patient's airway, while lower-concentration versions (10% or less) may provide similar benefits without explosion risk.
Summary
This study reviewed explosion incidents involving hydrogen gas inhalers used in medical settings, including device explosions reported in Japan and one documented case of an explosion inside a patient's lungs. Researchers found that inhalers containing more than 10% hydrogen gas pose serious explosion risks, while lower-concentration inhalers (10% or less) appear to work effectively without creating dangerous conditions.
Practical Takeaway
If you're considering hydrogen inhalers, this analysis suggests that devices with 10% or lower hydrogen concentration are significantly safer than higher-concentration versions. However, this study reviewed safety incidents rather than testing efficacy directly, so evidence for hydrogen's actual health benefits remains limited. Anyone using hydrogen therapy should verify their device's hydrogen concentration and consult their healthcare provider about safety.
Abstract
BackgroundWith the growing recognition of the medical applications of hydrogen, hydrogen gas inhalers are increasingly used in clinics and other healthcare settings. However, hydrogen is highly explosive, and numerous explosion incidents involving these inhalers have been reported.ObjectivesThis study evaluates the safety risks of high-concentration hydrogen inhalers (67%-99.99% v/v H2) following multiple device explosions and a documented pulmonary explosion case, and to determine an optimal concentration balancing safety and efficacy.MethodsWe analyzed device explosion incidents recorded by the Consumer Affairs Agency of Japan and an in-body hydrogen explosion case reported in a 2024 scientific paper, and subsequently discussed the factors contributing to these accidents based on the explosive properties of hydrogen gas.ResultsHigh-concentration inhalers (>10% v/v H2) pose a substantial explosion risk, as confirmed by multiple device failures reported by Japan's Consumer Affairs Agency and a 2024 in-vivo pulmonary explosion case. Limiting hydrogen to ≤10% v/v maintains efficacy for intracellular hydroxyl radical scavenging while staying below the lower explosive limit.ConclusionTwo critical preventable hazards exist with high-concentration hydrogen therapy: external device explosion and internal airway detonation. Immediate transition to low-concentration (≤10% v/v H2) inhalers is strongly recommended, as they provide effective concentration while eliminating life-threatening risks, ensuring patient safety without compromising clinical outcomes.